Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Hiscox CEO invests; Coca-Cola HBC counsel exercises, sells options

(Sharecast News) - Hiscox was among those on the list of director buys on Friday, after its chief executive officer added to his holding. The FTSE 100 company said Aki Hussain picked up 15,000 shares on 29 August, in a single transaction on the London Stock Exchange.

Hussain paid 1,004p for each share, valuing the transaction at a total of £150,600.

On the selling side of the ledger was Coca-Cola HBC, after its general counsel and company secretary exercised a tranche of share options before selling the shares.

The FTSE 100 drinks bottling giant said Jan Gustavsson exercised 30,000 share options at a strike price of 1,256p apiece, giving that side of the transaction a value of £376,800.

Gustavsson then sold the 30,000 shares on London's market, at a price of 2,310p apiece, giving the sale on 31 August a value of £693,000.

At 1317 BST, shares in Hiscox were up 0.75% at 1,005p, while those in Coca-Cola HBC were 0.66% weaker at 2,263p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Hiscox Limited (di) (HSX) Director name: Hussain,Hamayou Akbar Amount purchased: 15,000 @ 1,004.00p Value: �150,600.00

Vaalco Energy, Inc (di) (EGY) Director name: Maxwell,George Walter Mitchell Amount purchased: 5,000 @ $4.11 Value: $16,945.25

Vaalco Energy, Inc (di) (EGY) Director name: Fawthrop,Andrew L Amount purchased: 4,000 @ $4.11 Value: $13,549.93

Top Director Sells

Coca-cola Hbc Ag (cdi) (CCH) Director name: Bogdanovic,Zoran Amount sold: 5,528 @ 2,315.00p Value: �127,973.20

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 2,425 @ $3.70 Value: $7,398.78

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 1,501 @ $3.70 Value: $4,579.62

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 393 @ $3.70 Value: $1,200.68

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 393 @ $3.70 Value: $1,200.68

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 309 @ $3.73 Value: $950.42

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 165 @ $3.72 Value: $506.14

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 107 @ $3.71 Value: $327.34

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 100 @ $3.70 Value: $305.10

Share this article

Related Sharecast Articles

Director dealings: Personal Group CFO makes share sale
(Sharecast News) - Personal Group revealed on Thursday that chief financial officer Sarah Mace had disposed of 3,410 ordinary shares in the AIM-listed workforce benefits and services provider.
Director dealings: Roadside Real Estate chairman's wife snaps up shares
(Sharecast News) - Roadside Real Estate revealed on Wednesday that chairman Charles Dickson's wife, Helen, had acquired 879,678 ordinary shares in the AIM-listed real estate business.
Director dealings: Literacy Capital director makes share purchase
(Sharecast News) - Literacy Capital revealed on Tuesday that director Christopher Sellers had acquired 17,500 ordinary shares in the London-listed investment company.
Director dealings: Primary Health Properties CEO makes share purchase
(Sharecast News) - Primary Health Properties revealed on Monday that chief executive officer Harry Hyman had acquired 74,890 ordinary shares in the FTSE 250-listed real estate investment trust.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.